BIOFERMENTED NAD+
Live / Applied — Non-final action mailed (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 21 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99295172
- Mark type
- Stylized text
- Filed
- 21 Jul 2025
- Attorney of record
- KAVEH NEWMEN
Goods and services
- Class 001 — Chemicals: Coenzymes for scientific and laboratory research purposes, namely, nicotinamide adenine dinucleotide (NAD+) produced by biofermentation for use as a research reagent
- Class 005 — Pharmaceuticals: Synthetic peptides for the treatment of of cellular aging and metabolic dysfunction; Synthetic peptides for the treatment of NAD+-deficiency related disorders
Owner
- Capsunova BioTech Group LLC, Wyoming, WY, US
Prosecution history
- 31 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION E-MAILED
- 31 Mar 2026 — NON-FINAL ACTION WRITTEN
- 10 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Dec 2025 — NON-FINAL ACTION E-MAILED
- 10 Dec 2025 — NON-FINAL ACTION WRITTEN
- 08 Dec 2025 — ASSIGNED TO EXAMINER
- 30 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Jul 2025 — NEW APPLICATION ENTERED